Transformation of Antibody Status in HIV/AIDS Patients Treated with Medicinal synthetic Aluminum-magnesium silicate {Al4 (SiO4)3 + 3Mg2SiO4 → 2Al2Mg3 (SiO4)3}

Authors

  • Pleasant Favour

Keywords:

mopping pathogens, nhancing immunity, learing secondary infections, ams-nanoparticles, electrostatic attraction

Abstract

Since viruses and abnormal cells are electrically charged, we postulated opposite charges electrostatic-mopping as treatment-mechanism for viral diseases and tumors. Molecules of Aluminum-magnesium silicate (AMS), WHO- approved medicine/adjuvant, consist of Nano- particles with positive and negative ends. Their ultra-small size (0.96 nm) enables them get to all organs to mop viruses and abnormal cells. As an adjuvant and a silicate, AMS improves antimicrobials` efficacies and enhances patients` immunity. Mopping HIV and HIV-infected cells, clearing secondary infections and enhancing immunity cure viral diseases and tumors. AMS-deposits may not exist in some countries and the medicine is un-absorbable. So, Aluminum silicate and Magnesium silicate (approved medicines) were used to formulate AMS-brand, named Medicinal synthetic AMS {MSAMS: Al4 (SiO4)3 + 3Mg2SiO4 → 2Al2Mg3 (SiO4)3}. Dextrose monohydrate was incor- porated to transport it into blood-circulation. That MSAMS-treated patient remained HIV- negative, 10 months post treatment has already been reported. Another patient monitored for 34 months also remained negative.

References

G. F. Brooks (1998) Medical microbiology.

Cristina E, Ivan P, Kevin R (2007) Nanomaterials and nanoparticles: Sources and toxicity. 2, MR17-MR71.

(2012) Technical Information %E2%80%9CVEEGUM-The versatile Incredent for pharmaceutical Formulations. (91R).

A. J. Cann (1993) Principles of molecular biology.

S Schils (2002) The use of montmorillonite in the fight against harmful effects of ammonia. 4(2), 32-36.

K. R. Murray (2000) Harper's Biochemistry.

M. Gentile, T. Adrian, A. Scheidler, M. Ewald, F. Dianzani, G. Pauli, H. R. Gelderblon (1994) Determination of the size of HIV using Adenovirus type 2 as an internal length marker. 4(1), 43-52.

M Yokoyama (2011) Structural Mechanisms of Immune Evasion of HIV 1 gp 120 by Genomic Computational and Experimental Science. 49-57. https://doi.org/10.2222/jsv.61.49

Steve Haltiwanger (2011) The Electrical Properties of Cancer Cells. http://www.royalrife.com/haltiwanger1

V.P Denis, K Lasse (2013) Students discover methods to kill cancer.

L. Suni, Hiroaki H., Megumi M., Hidenori M., Aoko K. T, Ying C., Kozo U, Masayasu K., Yasumitsu N, Takemi O. T (2014) Immunostimulation by Silica Particles and the Development of Autoimmune Dysregulation.

Brent W, Gigi H, K.H.I Ross, C.R John (2001) What do we really know about antibiotics pharmacodynamics?. 28-31.

M. C. O. Ezeibe, N. K Aneke, T. N Obarezi, F Onyeachonam, M. E. Sanda, I. J. Ogbonna, E. Kalu, U. N Njoku, M Udobi, O. E Ekundayo, O. I. O Ifenkwe, M. C Igwe, T. O Ogbodo, U. C Agu (2019) Cure for HIV/AIDS with Medicinal synthetic Aluminum magnesium silicate. 161-166.

M.C.O. Ezeibe, I.J. Ogbonna (2015) Acquired Immune Deficiency Syndrome in Man and Animals%E2%80%94A Review. 50-57.

M. C. O. Ezeibe, D. Aleeyu, N. K. Aneke, T. N. Obarezi, I. J. Ogbonna, E. Kalu, N. U. Njoku (2017) Effective Treatment of HIV/AIDS with the Medicinal Synthetic Aluminum-Magnesium Silicate. 1.

Published

2023-08-19

How to Cite

Transformation of Antibody Status in HIV/AIDS Patients Treated with Medicinal synthetic Aluminum-magnesium silicate {Al4 (SiO4)3 + 3Mg2SiO4 → 2Al2Mg3 (SiO4)3}. (2023). London Journal of Medical and Health Research, 23(8), 27-30. https://journalspress.uk/index.php/LJMHR/article/view/344